| Ytd | -53.77% | |
| 1y | -52.70% |
| Open | 1.78 | Prev Close | 1.77 | Low | 1.76 | High | 1.85 | Mkt Cap | 212.09M |
| Vol | 312.96K | Avg Vol | 589.75K | EPS | -0.39 | P/E | -4.72 | Forward P/E | N/A |
| Beta | 1.47 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-14 | 50-d Avg | 1.73 | 200-d Avg | 2.94 | 1yr Est | 0.00 |
NBP News
Woodside Energy Group (ASX: WDS) (NYSE: WDS):2026 full-year guidancePriorCurrentTotal production vol
ROCKVILLE, Md., July 24, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge”
Shares of I-Mab (NASDAQ: NBP - Get Free Report) dropped 4.9% during mid-day trading on Wednesday. Th
ROCKVILLE, Md., June 29, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge”
Registrational Phase 3 Trial Expected to Begin as Early as Q4 2026 Detailed Phase 1b Data Expected t
ROCKVILLE, Md., May 28, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or
ROCKVILLE, Md., May 12, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or
Seasoned Biopharma leader bringing deep commercial experience to shape and inform corporate strategy
NovaBridge Biosciences remains a high-risk, catalyst-driven biotech, trading near cash value with a
ROCKVILLE, Md., April 07, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge
FDA confirmed givastomig's potential eligibility for an accelerated approval pathway NovaBridge expe
NovaBridge Biosciences (NBP) Discusses Phase 2a Clinical Data and Development Plan for VIS-101 in We
NovaBridge Biosciences (NASDAQ: NBP) shares are up on Monday following the announcement of positive
ROCKVILLE, Md., March 09, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge
Ooma (NYSE:OOMA) shares rose 11.3% after beating Q4 earnings and revenue expectations. Other gainers
VIS-101, purpose-designed to be a best-in-class dual VEGF-A/ANG-2 inhibitor, has the potential to pr
ROCKVILLE, Md., March 02, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge
ROCKVILLE, Md., Feb. 19, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge o
ROCKVILLE, Md., Feb. 17, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge o
ROCKVILLE, Md., Jan. 20, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge o
NovaBridge stock was trading higher Tuesday but has since reversed and begun trading lower. NovaBrid
